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a b s t r a c t
Atorvastatin is a drug of the statin group which possesses the ability to decrease low-density lipoprotein
cholesterol level by the competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
There is a hypothesis that pharmacological properties of statins depend on their location in the cell
membrane. Intermolecular complex of atorvastatin with dodecylphosphocholine (DPC) micelle was
investigated by NMR and computational methods. The results of NMR experiments showed that
atorvastatin forms molecular complex with model membrane in solution by penetrating a space between
hydrocarbon chains of the DPC micelle. Analysis of obtained data in comparison with previously reported
results for simvastatin, pravastatin, ﬂuvastatin and cerivastatin showed that locations of statins in
model membranes correlate with their pharmacological features, such as efﬁcacy and risk of
rhabdomyolysis.
© 2018 Elsevier B.V. All rights reserved.
1. Introduction
Atorvastatin is a drug of the statin group which possesses the
ability to decrease low-density lipoprotein (LDL) cholesterol level
by the competitive inhibition of 3-hydroxy-3-methylglutaryl co-
enzyme A (HMG-CoA) reductase. It is a calcium salt containing a
fragment of b,d-dihydroxy-heptanoic acid, an analogue of
mevalonate [1,2]. Even though all statins share common phar-
macophore group essential for inhibition of cholesterol biosyn-
thesis their pleiotropic features are quite different [3e7]. Different
trials and clinical ﬁndings support the hypothesis that there are
important intermolecular differences responsible for broader
pharmacologic actions of statins, even beyond HMG-CoA reduc-
tase inhibition [8,9]. Nevertheless, by now there is no deﬁnitive
explanation for the origin of differences in efﬁciency, safety, and
potential non-LDL actions of statins. There is a hypothesis that
pharmacological properties of statins depend on their location in
the cell membrane [10e13]. There is a lack of studies on statins
interactions with the surface of the cell membrane in solid state,
and there is almost no such information about interactions in
liquid media presented in literature. However, this information is
necessary for understanding of physiological actions of the drugs
because solution is a native environment for the processes in
human organism.
One of themost effectivemethods for investigation of molecular
structure of different medicines in liquids is nuclear magnetic
resonance spectroscopy [14e17]. It is allowing determination of
molecular spatial structure and the structure of molecular com-
plexes using the most effective for such purposes technique NOESY,
which is based on a measurement of nuclear Overhauser effect
(NOE). Unfortunately, there are difﬁculties in studying interactions
of drugs with cell surface in solution directly by NMR due to very
short T2 proton relaxation times of phospholipid membranes
leading to extensive broadening of NMR signals [18,19]. Even so,
complexation of different pharmaceuticals with cell membranes
can be effectively studied by NMR using model systems such as
dodecylphosphocholine (DPC) micelles, which are widely used for
imitation of cell membrane in the NMR experiments [20e23]. DPC
molecule contains the same head group as phosphatidylcholines
and, therefore, effectively mimics eukaryotic membrane. Our group
previously has shown that pravastatin, simvastatin, ﬂuvastatin and
cerivastatin form intermolecular complexes with model mem-
branes, and the structures of the complexes are different
[13,24e26]. It was suggested that distinctions in locations of statins* Corresponding author.
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